Natixis Advisors, LLC’s Astrazeneca PLC Position
Does Natixis Advisors, LLC own Astrazeneca PLC (AZNN)? Not currently — the last reported position was 2.05M shares worth $189M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$189M
Q4 2025
Shares
2.05M
% of Portfolio
+0.27%
Quarters Held
29
position exited
Position History AZNN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 2.05M | $189M | +0.27% |
| Q3 2025 | 2.10M | $161M | +0.24% |
| Q2 2025 | 1.84M | $128M | +0.20% |
| Q1 2025 | 2.24M | $164M | +0.30% |
| Q4 2024 | 2.06M | $135M | +0.25% |
| Q3 2024 | 1.96M | $153M | +0.30% |
| Q2 2024 | 1.84M | $144M | +0.31% |
| Q1 2024 | 1.57M | $106M | +0.24% |
| Q4 2023 | 1.25M | $84M | +0.22% |
| Q3 2023 | 1.17M | $79M | +0.24% |
| Q2 2023 | 1.13M | $81M | +0.25% |
| Q1 2023 | 1.00M | $70M | +0.24% |
| Q4 2022 | 883.2K | $60M | +0.23% |
| Q3 2022 | 904.9K | $50M | +0.21% |
| Q2 2022 | 637.9K | $42M | +0.19% |
| Q1 2022 | 640.2K | $42M | +0.16% |
| Q4 2021 | 592.3K | $35M | +0.13% |
| Q3 2021 | 592.3K | $36M | +0.15% |
| Q2 2021 | 491.7K | $29M | +0.14% |
| Q1 2021 | 418.9K | $21M | +0.11% |
| Q4 2020 | 362.6K | $18M | +0.10% |
| Q3 2020 | 370.4K | $20M | +0.13% |
| Q2 2020 | 389.9K | $21M | +0.14% |
| Q1 2020 | 390.9K | $17M | +0.14% |
| Q4 2019 | 408.9K | $20M | +0.14% |
| Q3 2019 | 486.3K | $22M | +0.17% |
| Q2 2019 | 616.5K | $25M | +0.21% |
| Q1 2019 | 607.5K | $25M | +0.22% |
| Q4 2018 | 618.8K | $24M | +0.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of AZNN.